Literature DB >> 14644095

Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene.

Maria E C Bruno1, Ryan B West, Tracey A Schneeman, Emery H Bresnick, Charlotte S Kaetzel.   

Abstract

Secretory antibodies protect mucosal surfaces from ingested, inhaled and sexually transmitted pathogens. The polymeric immunoglobulin receptor (pIgR) transports antibodies across mucosal epithelia into external secretions. We and others have identified a region of the human polymeric immunoglobulin receptor gene (locus PIGR) that is sufficient for basal transcriptional activity. An E-Box motif, which binds transcription factors of the basic helix-loop-helix/leucine zipper (bHLH/zip) family, was identified as a major regulatory element in the PIGR gene promoter. Transient transfection of PIGR promoter reporter plasmids in intestinal epithelial cell (IEC) lines suggested that the transcription factors upstream stimulatory factor (USF) and c-Myc may exert opposing effects on PIGR promoter activity. Mutations within and flanking the E-Box that favored USF binding enhanced promoter activity, while mutations that favored c-Myc binding reduced promoter activity. Ectopic expression of USF1 or USF2 enhanced PIGR promoter activity, while exogenous c-Myc did not. Electrophoretic mobility shift assays (EMSA) demonstrated that USF1 and USF2 bound to the E-Box motif as homo- and heterodimers. Chromatin immunoprecipitation (ChIP) demonstrated that USF proteins bind the PIGR promoter in vivo, which is enriched in acetylated histones. E-Box motifs are commonly observed in promoters of genes that are highly expressed in the human colon. Genes that are down-regulated in colorectal cancer, including PIGR, frequently have non-canonical E-Boxes, while genes that are up-regulated in colorectal cancer generally have canonical E-Boxes. The results of our experiments may shed light on the mechanisms of dysregulated expression of pIgR in inflammatory bowel disease and colorectal cancer, diseases associated with aberrant expression of c-Myc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14644095     DOI: 10.1016/j.molimm.2003.09.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Upstream stimulatory factor-2 mediates quercetin-induced suppression of PAI-1 gene expression in human endothelial cells.

Authors:  Nélida C Olave; Maximiliano H Grenett; Martin Cadeiras; Hernan E Grenett; Paul J Higgins
Journal:  J Cell Biochem       Date:  2010-10-15       Impact factor: 4.429

2.  TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF.

Authors:  Jiguo Chen; Tom Malcolm; Mario C Estable; Robert G Roeder; Ivan Sadowski
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription.

Authors:  Thomas D Hock; Harry S Nick; Anupam Agarwal
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

4.  Regulation of the polymeric immunoglobulin receptor by the classical and alternative NF-κB pathways in intestinal epithelial cells.

Authors:  M E C Bruno; A L Frantz; E W Rogier; F-E Johansen; C S Kaetzel
Journal:  Mucosal Immunol       Date:  2011-03-30       Impact factor: 7.313

5.  GTRD: a database of transcription factor binding sites identified by ChIP-seq experiments.

Authors:  Ivan Yevshin; Ruslan Sharipov; Tagir Valeev; Alexander Kel; Fedor Kolpakov
Journal:  Nucleic Acids Res       Date:  2016-10-24       Impact factor: 16.971

6.  Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis.

Authors:  Di Wang; Jian Zheng; Xiaobai Liu; Yixue Xue; Libo Liu; Jun Ma; Qianru He; Zhen Li; Heng Cai; Yunhui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2019-01-15       Impact factor: 8.886

7.  hsa-miR-875-5p inhibits tumorigenesis and suppresses TGF-β signalling by targeting USF2 in gastric cancer.

Authors:  Shenshuo Gao; Zhikai Zhang; Xubin Wang; Yan Ma; Chensheng Li; Hongjun Liu; Changqing Jing; Leping Li; Xiaobo Guo
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.